Patents by Inventor Birge Bargmann

Birge Bargmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
    Publication number: 20230285524
    Abstract: The present invention relates to the use of elafin for the treatment and/or prevention of diseases or disorders associated with an increase in troponin levels, which are non elastase dependent. The present invention in a preferred embodiment relates to a method and composition, using elafin, for protecting the heart muscle or other muscles from damage induced by abnormal blood flow and/or inflammation, which may result from, for example, a heart infarction. The present invention additionally or concomitantly relates to the use of elafin for the treatment and/or prevention of disorders or diseases which are associated with a rise in the level of troponin I and/or T.
    Type: Application
    Filed: December 19, 2022
    Publication date: September 14, 2023
    Inventors: Birge BARGMANN, Oliver WIEDOW, Peter HENRIKSEN
  • USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
    Publication number: 20220133867
    Abstract: The present invention relates to the use of elafin for the treatment and/or prevention of diseases or disorders associated with an increase in troponin levels, which are non elastase dependent. The present invention in a preferred embodiment relates to a method and composition, using elafin, for protecting the heart muscle or other muscles from damage induced by abnormal blood flow and/or inflammation, which may result from, for example, a heart infarction. The present invention additionally or concomitantly relates to the use of elafin for the treatment and/or prevention of disorders or diseases which are associated with a rise in the level of troponin I and/or T.
    Type: Application
    Filed: December 17, 2021
    Publication date: May 5, 2022
    Inventors: Birge BARGMANN, Oliver Wiedow, Peter Henriksen
  • USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
    Publication number: 20220111021
    Abstract: The present invention relates to the use of elafin for the treatment and/or prevention of diseases or disorders associated with an increase in troponin levels, which are non elastase dependent. The present invention in a preferred embodiment relates to a method and composition, using elafin, for protecting the heart muscle or other muscles from damage induced by abnormal blood flow and/or inflammation, which may result from, for example, a heart infarction. The present invention additionally or concomitantly relates to the use of elafin for the treatment and/or prevention of disorders or diseases which are associated with a rise in the level of troponin I and/or T.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Inventors: Birge BARGMANN, Oliver WIEDOW, Peter HENRIKSEN
  • USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
    Publication number: 20190255158
    Abstract: The present invention relates to the use of elafin for the treatment and/or prevention of diseases or disorders associated with an increase in troponin levels, which are non elastase dependent. The present invention in a preferred embodiment relates to a method and composition, using elafin, for protecting the heart muscle or other muscles from damage induced by abnormal blood flow and/or inflammation, which may result from, for example, a heart infarction. The present invention additionally or concomitantly relates to the use of elafin for the treatment and/or prevention of disorders or diseases which are associated with a rise in the level of troponin I and/or T.
    Type: Application
    Filed: May 6, 2019
    Publication date: August 22, 2019
    Inventors: Birge Bargmann, Oliver Wiedow, Peter Henriksen
  • USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
    Publication number: 20180221462
    Abstract: The present invention relates to the use of elafin for the treatment and/or prevention of diseases or disorders associated with an increase in troponin levels, which are non elastase dependent. The present invention in a preferred embodiment relates to a method and composition, using elafin, for protecting the heart muscle or other muscles from damage induced by abnormal blood flow and/or inflammation, which may result from, for example, a heart infarction. The present invention additionally or concomitantly relates to the use of elafin for the treatment and/or prevention of disorders or diseases which are associated with a rise in the level of troponin I and/or T.
    Type: Application
    Filed: August 24, 2015
    Publication date: August 9, 2018
    Inventor: Birge Bargmann
  • NOVEL USES OF ELAFIN
    Publication number: 20140287985
    Abstract: The invention relates to novel uses of the polypeptide elafin, and/or homologues, derivatives or fragments thereof having inhibitory activity against leukocyte elastase for the prevention and treatment of medical conditions like SIRS.
    Type: Application
    Filed: June 9, 2014
    Publication date: September 25, 2014
    Applicant: Proteo Biotech AG
    Inventors: Oliver Wiedow, Birge Bargmann, Barbara Kahlke, Lee Shaw, Nils Wichmann
  • NOVEL USES OF ELAFIN
    Publication number: 20130281383
    Abstract: The invention relates to novel uses of the polypeptide elafin, and/or homologies, derivatives or fragments thereof having inhibitory activity against leukocyte elastase for the prevention and treatment of medical conditions like SIRS.
    Type: Application
    Filed: March 2, 2011
    Publication date: October 24, 2013
    Applicant: PROTEO BIOTECH AG
    Inventors: Oliver Wiedow, Birge Bargmann, Barbara Kahlke, Lee Shaw, Nils Wichmann